JPMORGAN CHASE & CO

Position in AVBP — ArriVent BioPharma, Inc.

CIK 19617 NEW YORK, NY

Position in AVBP

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,519,827

+$123,621 QoQ

Shares Held

65,879

-5.1% QoQ

Ownership

0.141%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 73% Shared 0% None 27%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. AVBP ranks #152 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	24,150,499	$3,949,089,591
2	REGN	Regeneron Pharmaceuticals, Inc.	4,311,806	$3,331,473,778
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,033,156	$3,140,585,469
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,323,752	$2,092,339,815
5	NUVL	Nuvalent, Inc.	3,088,349	$316,401,351
6	JAZZ	Jazz Pharmaceuticals plc	1,204,353	$227,682,931
7	IONS	Ionis Pharmaceuticals Inc	2,363,567	$177,480,242
8	TERN	Terns Pharmaceuticals, Inc.	2,869,728	$151,292,056

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,519,827	65,879	-5.1%	Shares	Defined	2026-05-13
2025-12-31	$1,396,206	69,394	+396.0%	Shares	Defined	2026-02-11
2025-09-30	$258,132	13,991	-2.9%	Shares	Defined	2025-11-26
2025-06-30	$313,682	14,409	-11.8%	Shares	Defined	2025-08-12
2025-03-31	$301,922	16,329	+4.1%	Shares	Defined	2025-05-12
2024-12-31	$417,846	15,685	+26.0%	Shares	Defined	2025-02-12
2024-09-30	$292,457	12,445	+183.2%	Shares	Defined	2024-12-26
2024-06-30	$81,526	4,395	-65.0%	Shares	Defined	2024-12-26
2024-03-31	$224,249	12,556	—	Shares	Defined	2024-12-26
No filing history on record for this holder in this stock.